Q4 2024 Earnings Call Transcript March 20, 2025 Monte Rosa Therapeutics, Inc. beats earnings expectations. Reported EPS is $0 ...
Sibanye Stillwater ADRs surged 30% YTD, but palladium headwinds and mine impairments pose challenges. See why we are neutral ...
More delays expected after fire chaos as airport says it’s now fully operational again - Heathrow Airport is back in business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results